BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ögren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23 796 consecutive autopsies. World J Gastroenterol 2006; 12(13): 2115-2119 [PMID: 16610067 DOI: 10.3748/wjg.v12.i13.2115] [Cited by in CrossRef: 254] [Cited by in F6Publishing: 194] [Article Influence: 16.9] [Reference Citation Analysis]
Number Citing Articles
1 Agarwal KK, Shah D, Shah N, Mayank M. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT. Clin Nucl Med. 2017;42:e472-e474. [PMID: 28922192 DOI: 10.1097/rlu.0000000000001840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Causes of adult splanchnic vein thrombosis in the mediterranean area. Mediterr J Hematol Infect Dis. 2011;3:e2011063. [PMID: 22220260 DOI: 10.4084/mjhid.2011.063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Cheng Q, Tree K. Systematic Review of Thrombolysis Therapy in the Management of Non-Cirrhosis-Related Portal Vein Thrombosis. J Gastrointest Surg 2021;25:1579-90. [PMID: 33452971 DOI: 10.1007/s11605-020-04624-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Osman AMA, Helmy AS, Mikhail S, AlAyat AA, Serour DK, Ibrahim MY. Early Effects of Laparoscopic Sleeve Gastrectomy and Laparoscopic One-Anastomosis Gastric Bypass on Portal Venous Flow: a Prospective Cohort Study. Obes Surg 2021;31:2410-8. [PMID: 33660156 DOI: 10.1007/s11695-021-05267-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rössle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, Caca K, Mücke VT, Radecke K, Engelmann C, Zipprich A, Heinzow H, Meyer C, Tappe U, Appenrodt B, Schmidt A, Lange C, Strassburg C, Zeuzem S, Grandt D, Schmidt H, Moessner J, Berg T, Lammert F, Thimme R, Schultheiß M. A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment. Aliment Pharmacol Ther 2020;52:329-39. [PMID: 32506456 DOI: 10.1111/apt.15811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
6 Sinagra E, Aragona E, Romano C, Maisano S, Orlando A, Virdone R, Tesè L, Modesto I, Criscuoli V, Cottone M. The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature. Gastroenterol Res Pract. 2012;2012:916428. [PMID: 23093957 DOI: 10.1155/2012/916428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, Marrero JA, Pelletier SJ. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16:83-90. [PMID: 20035521 DOI: 10.1002/lt.21941] [Cited by in Crossref: 146] [Cited by in F6Publishing: 129] [Article Influence: 13.3] [Reference Citation Analysis]
8 Kojima S, Watanabe N, Koizumi J, Kokubu S, Murashima N, Matsutani S, Obara K. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension: Current status of portal vein thrombosis in Japan. Hepatol Res 2018;48:244-54. [DOI: 10.1111/hepr.12983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Hirashita T, Ohta M, Kai S, Masuda T, Eguchi H, Iwashita Y, Ogawa T, Kitano S. Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension. Surg Today. 2011;41:1475-1480. [PMID: 21969148 DOI: 10.1007/s00595-010-4523-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
10 Ersoy H. The Role of Noninvasive Vascular Imaging in Splanchnic and Mesenteric Pathology. Clinical Gastroenterology and Hepatology 2009;7:270-8. [DOI: 10.1016/j.cgh.2008.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Costache RS, Dragomirică AS, Dumitraș EA, Mariana J, Căruntu A, Popescu A, Costache DO. Portal vein thrombosis: A concise review (Review). Exp Ther Med 2021;22:759. [PMID: 34035856 DOI: 10.3892/etm.2021.10191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tublin ME, Towbin AJ, Federle MP, Nalesnik MA. Altered liver morphology after portal vein thrombosis: not always cirrhosis. Dig Dis Sci 2008;53:2784-8. [PMID: 18270830 DOI: 10.1007/s10620-008-0201-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
13 Mier-Hicks A, Raj M, Do RK, Yu KH, Lowery MA, Varghese A, O'Reilly EM. Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma. Clin Colorectal Cancer. 2018;17:121-128. [PMID: 29477452 DOI: 10.1016/j.clcc.2018.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
14 Serag WM, Mohammed BSE, Mohamed MM, Elsayed BE. Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma. Heliyon 2020;6:e04677. [PMID: 32904199 DOI: 10.1016/j.heliyon.2020.e04677] [Reference Citation Analysis]
15 Ageno W. Managing unusual presentations of venous thromboembolism. J Thromb Thrombolysis 2015;39:304-10. [DOI: 10.1007/s11239-015-1171-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: When to treat and how? Vasc Med. 2016;21:61-69. [PMID: 26584887 DOI: 10.1177/1358863x15611224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
17 Hayashi T, Takatori H, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Kitamura K, Kawaguchi K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Toyama T, Okumura K, Kozaka K, Kaneko S. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterol 2019;19:217. [PMID: 31842768 DOI: 10.1186/s12876-019-1140-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev. 2014;28:107-113. [PMID: 24721432 DOI: 10.1016/j.tmrv.2014.03.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 11.9] [Reference Citation Analysis]
19 Loudin M, Ahn J. Portal Vein Thrombosis in Cirrhosis. J Clin Gastroenterol. 2017;51:579-585. [PMID: 28489645 DOI: 10.1097/mcg.0000000000000834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Bartolotta TV, Taibbi A, Midiri M, Lagalla R. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand? Ultrasonography 2019;38:200-14. [PMID: 31006227 DOI: 10.14366/usg.18060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
21 Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis. 2017;49:113-120. [PMID: 27965037 DOI: 10.1016/j.dld.2016.11.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
22 Brennan IM, Ahmed M. Portal vein thrombosis following percutaneous transhepatic cholangiography-An unusual presentation of Prothrombin (Factor II) gene mutation. World J Radiol 2012;4:224-7. [PMID: 22761983 DOI: 10.4329/wjr.v4.i5.224] [Reference Citation Analysis]
23 Al-Holou S, Mathur AK, Ranney D, Kubus J, Englesbe MJ. Survival among children with portal vein thrombosis and end-stage liver disease. Pediatr Transplant 2010;14:132-7. [PMID: 19413719 DOI: 10.1111/j.1399-3046.2009.01175.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
24 De Stefano V, Martinelli I. Abdominal thromboses of splanchnic, renal and ovarian veins. Best Pract Res Clin Haematol 2012;25:253-64. [PMID: 22959542 DOI: 10.1016/j.beha.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
25 Søgaard KK, Horváth-Puhó E, Montomoli J, Vilstrup H, Sørensen HT. Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism. Clin Transl Gastroenterol. 2015;6:e97. [PMID: 26133110 DOI: 10.1038/ctg.2015.27] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
26 Ascenti G, Sofia C, Silipigni S, Vinci S, Pergolizzi S, Marin D, Mileto A, Mazziotti S. Dual-Energy Multidetector Computed Tomography with Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced Phase? Can Assoc Radiol J 2015;66:348-55. [DOI: 10.1016/j.carj.2015.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 De Maria C, Galante A, Fasoli A, De Gottardi A. When and how to use direct oral anticoagulants in patients with advanced chronic liver disease? Curr Opin Pharmacol 2021;60:111-6. [PMID: 34403992 DOI: 10.1016/j.coph.2021.07.006] [Reference Citation Analysis]
28 Chammas MC, Oliveira AC, D Ávilla MJ, Moraes PH, Takahashi MS. Characterization of Malignant Portal Vein Thrombosis with Contrast-Enhanced Ultrasonography. Ultrasound Med Biol 2019;45:50-5. [PMID: 30366607 DOI: 10.1016/j.ultrasmedbio.2018.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
29 Wang L, He F, Yue Z, Zhao H, Fan Z, Zhao M, Qiu B, Yao J, Lin Q, Dong X, Liu F. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein. Sci Rep. 2017;7:10868. [PMID: 28883536 DOI: 10.1038/s41598-017-11455-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
30 Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W. Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res. 2012;130 Suppl 1:S1-S3. [PMID: 23026649 DOI: 10.1016/j.thromres.2012.08.259] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
31 Kukla M, Waluga M, Żorniak M, Berdowska A, Wosiewicz P, Sawczyn T, Bułdak RJ, Ochman M, Ziora K, Krzemiński T, Hartleb M. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol 2017;23:2613-24. [PMID: 28465646 DOI: 10.3748/wjg.v23.i14.2613] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
32 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis. 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
33 del Carmen Manzano-robleda M, Barranco-fragoso B, Uribe M, Méndez-sánchez N. Portal vein thrombosis: What is new? Annals of Hepatology 2015;14:20-7. [DOI: 10.1016/s1665-2681(19)30797-5] [Cited by in Crossref: 34] [Article Influence: 5.7] [Reference Citation Analysis]
34 DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 408] [Article Influence: 49.9] [Reference Citation Analysis]
35 Donadini MP, Dentali F, Ageno W. Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012;129 Suppl 1:S93-6. [PMID: 22682143 DOI: 10.1016/S0049-3848(12)70025-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
36 Ponziani FR, De Stefano V, Gasbarrini A. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis 2009;1:e2009033. [PMID: 21415961 DOI: 10.4084/MJHID.2009.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Raza SA, Jang HJ, Kim TK. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdom Imaging. 2014;39:153-161. [PMID: 24002440 DOI: 10.1007/s00261-013-0034-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
38 Chatelin S, Pop R, Giraudeau C, Ambarki K, Jin N, Séverac F, Breton E, Vappou J. Influence of portal vein occlusion on portal flow and liver elasticity in an animal model. NMR Biomed 2021;34:e4498. [PMID: 33634498 DOI: 10.1002/nbm.4498] [Reference Citation Analysis]
39 Rabie H, Othman W, Elsabaawy DM, Elshemy EE, Abdelmageed N, Khalaf FA, Bedair HM. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2021;22:267-75. [PMID: 33507708 DOI: 10.31557/APJCP.2021.22.1.267] [Reference Citation Analysis]
40 Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology. 2010;254:154-162. [PMID: 20032150 DOI: 10.1148/radiol.09090304] [Cited by in Crossref: 128] [Cited by in F6Publishing: 107] [Article Influence: 11.6] [Reference Citation Analysis]
41 Shatzel JJ, O'Donnell M, Olson SR, Kearney MR, Daughety MM, Hum J, Nguyen KP, DeLoughery TG. Venous thrombosis in unusual sites: A practical review for the hematologist. Eur J Haematol 2019;102:53-62. [PMID: 30267448 DOI: 10.1111/ejh.13177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
42 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Hematology/Oncology Clinics of North America 2011;25:1049-66. [DOI: 10.1016/j.hoc.2011.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Qi X, Li H, Liu X, Yao H, Han G, Hu F, Shao L, Guo X. Novel insights into the development of portal vein thrombosis in cirrhosis patients. Expert Rev Gastroenterol Hepatol. 2015;9:1421-1432. [PMID: 26325361 DOI: 10.1586/17474124.2015.1083856] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
44 Saner FH, Bezinover D. Assessment and management of coagulopathy in critically-ill patients with liver failure. Curr Opin Crit Care. 2019;25:179-186. [PMID: 30855324 DOI: 10.1097/mcc.0000000000000591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
45 Wani ZA, Bhat RA, Bhadoria AS, Maiwall R. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification. Saudi J Gastroenterol 2015;21:129-38. [PMID: 26021771 DOI: 10.4103/1319-3767.157550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
46 Kanai F, Obi S, Fujiyama S, Shiina S, Tamai H, Mochizuki H, Koike Y, Imamura J, Yamaguchi T, Saida I, Yokosuka O, Omata M. An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma. Hepatol Int 2014;8:94-103. [DOI: 10.1007/s12072-013-9459-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
47 Elnaggar AS, Griesemer AD, Bentley-hibbert S, Brown RS, Martinez M, Lobritto SJ, Kato T, Emond JC. Liver atrophy and regeneration in noncirrhotic portal vein thrombosis: Effect of surgical shunts: Elnaggar et al. Liver Transpl 2018;24:881-7. [DOI: 10.1002/lt.25024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
48 Allaix ME, Krane MK, Zoccali M, Umanskiy K, Hurst R, Fichera A. Postoperative portomesenteric venous thrombosis: lessons learned from 1,069 consecutive laparoscopic colorectal resections. World J Surg. 2014;38:976-984. [PMID: 24240673 DOI: 10.1007/s00268-013-2336-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
49 Connolly GC, Chen R, Hyrien O, Mantry P, Bozorgzadeh A, Abt P, Khorana AA. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res. 2008;122:299-306. [PMID: 18045666 DOI: 10.1016/j.thromres.2007.10.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
50 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 5.9] [Reference Citation Analysis]
51 Lee DS, Seong J. Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis. Liver Cancer 2014;3:18-30. [PMID: 24804174 DOI: 10.1159/000343855] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
52 Rajesh S, Mukund A, Arora A. Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract 2015;2015:101029. [PMID: 26600801 DOI: 10.1155/2015/101029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
53 Madhusudhan KS, Vyas S, Sharma S, Srivastava DN, Gupta AK. Portal vein abnormalities: an imaging review. Clinical Imaging 2018;52:70-8. [DOI: 10.1016/j.clinimag.2018.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
54 Gawande R, Jalaeian H, Niendorf E, Olgun D, Krystosek L, Rubin N, Spilseth B. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction. Eur J Radiol 2019;118:88-95. [PMID: 31439264 DOI: 10.1016/j.ejrad.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
55 Wobser H, Schölmerich J, Büttner R. [19-year-old kick-boxer with hematemesis and splenomegaly]. Internist (Berl) 2010;51:213-8. [PMID: 19771406 DOI: 10.1007/s00108-009-2446-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, Re R, Bonzini M. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. ThrombHaemost. 2017;117:794-800. [PMID: 28180235 DOI: 10.1160/th16-10-0781] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 9.8] [Reference Citation Analysis]
57 Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther. 2010;10:507-519. [PMID: 20397916 DOI: 10.1586/era.10.24] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
58 Kim TK, Jang H, Wilson SR. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement. In: Carr BI, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2016. pp. 367-90. [DOI: 10.1007/978-3-319-34214-6_24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
59 Goldstein M, Quen L, Jacks L, Jhaveri K. Acute Abdominal Venous Thromboses—The Hyperdense CT Sign: . Journal of Computer Assisted Tomography 2012;36:8-13. [DOI: 10.1097/rct.0b013e3182436c86] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
60 Bucheeri MM, Abulsel AY. Case series: Portomesenteric venous thrombosis complicating laparoscopic bariatric procedures. Int J Surg Case Rep 2019;62:126-31. [PMID: 31494457 DOI: 10.1016/j.ijscr.2019.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Rodríguez-Leal GA, Morán S, Corona-Cedillo R, Brom-Valladares R. Portal vein thrombosis with protein C-S deficiency in a non-cirrhotic patient. World J Hepatol 2014;6:532-7. [PMID: 25068006 DOI: 10.4254/wjh.v6.i7.532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
62 Saugel B, Lee M, Feichtinger S, Hapfelmeier A, Schmid RM, Siveke JT. Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis. J Thromb Thrombolysis. 2015;40:54-60. [PMID: 25115839 DOI: 10.1007/s11239-014-1124-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
63 Parikh NS, Navi BB, Schneider Y, Jesudian A, Kamel H. Association Between Cirrhosis and Stroke in a Nationally Representative Cohort. JAMA Neurol 2017;74:927-32. [PMID: 28586894 DOI: 10.1001/jamaneurol.2017.0923] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
64 Abdel-Razik A, Mousa N, Shabana W, Yassen AH, Abdelsalam M, Wahba MM, Helmy EM, Tawfik AM, Zalata K, Hasan AS, Elhelaly R, Elzehery R, Fathy AA, El-Wakeel N, Eldars W. De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study. Front Med (Lausanne) 2021;8:650818. [PMID: 33996858 DOI: 10.3389/fmed.2021.650818] [Reference Citation Analysis]
65 Bozas G, Ramasamy S, Avery G, Maraveyas A. Unsuspected visceral venous thrombosis, in patients with cancer of the gastrointestinal system. Thromb Res 2012;130:682-4. [PMID: 22841662 DOI: 10.1016/j.thromres.2012.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
66 Congly SE, Lee SS. Portal vein thrombosis: should anticoagulation be used? Curr Gastroenterol Rep. 2013;15:306. [PMID: 23314804 DOI: 10.1007/s11894-012-0306-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
67 Olson MC, Lubner MG, Menias CO, Mellnick VM, Mankowski Gettle L, Kim DH, Elsayes KM, Pickhardt PJ. Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis: Causes and Imaging Findings. Radiographics 2020;40:875-94. [PMID: 32330086 DOI: 10.1148/rg.2020190097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
68 Liu K, Chen J, Zhang K, Wang S, Li X. A Diagnostic Prediction Model of Acute Symptomatic Portal Vein Thrombosis. Ann Vasc Surg 2019;61:394-9. [PMID: 31352086 DOI: 10.1016/j.avsg.2019.04.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
69 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
70 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol. 2019;25:4437-4451. [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
71 Malaguarnera G, Catania VE, Latteri S, Borzì AM, Bertino G, Madeddu R, Drago F, Malaguarnera M. Folate levels in hepatocellular carcinoma patients with portal vein thrombosis. BMC Gastroenterol 2020;20:375. [PMID: 33172390 DOI: 10.1186/s12876-020-01525-3] [Reference Citation Analysis]
72 Keil R, Koželuhová J, Dolina J, Hep A, Kroupa R, Kojecký V, Krejčí T, Havlín J, Hadačová I, Segethová J, Koptová P, Zádorová Z, Matouš J, Frýbová B, Chmátal P, Wasserbauer M, Šťovíček J, Bae M, Guven T, Zaeem M, Hlava Š. Acute portal vein thrombosis in noncirrhotic patients – different prognoses based on presence of inflammatory markers: a long-term multicenter retrospective analysis. Scandinavian Journal of Gastroenterology 2019;54:1379-84. [DOI: 10.1080/00365521.2019.1677768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Ma J, Yan Z, Luo J, Liu Q, Wang J, Qiu S. Rational classification of portal vein thrombosis and its clinical significance. PLoS One. 2014;9:e112501. [PMID: 25393320 DOI: 10.1371/journal.pone.0112501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
74 Rinaldi F, Lissandrin R, Mojoli F, Baldanti F, Brunetti E, Pascarella M, Giordani MT. Acute cytomegalovirus infection as a cause of venous thromboembolism. Mediterr J Hematol Infect Dis 2014;6:e2014041. [PMID: 24959338 DOI: 10.4084/MJHID.2014.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
75 Ventura P, Venturelli G, Marcacci M, Fiorini M, Marchini S, Cuoghi C, Pietrangelo A. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis. Thromb Res. 2016;141:189-195. [PMID: 27065203 DOI: 10.1016/j.thromres.2016.03.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
76 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings 2019;94:714-26. [DOI: 10.1016/j.mayocp.2018.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 12.5] [Reference Citation Analysis]
77 Donadini MP, Ageno W. Unusual site thrombosis. Semin Hematol 2011;48:264-70. [PMID: 22000092 DOI: 10.1053/j.seminhematol.2011.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
78 Wu M, Schuster M, Tadros M. Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants. J Clin Transl Hepatol 2019;7:154-64. [PMID: 31293916 DOI: 10.14218/JCTH.2018.00057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
79 Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B. Hemostatic Abnormalities in Cirrhosis and Tumor-Related Portal Vein Thrombosis. Clin Appl Thromb Hemost 2012;18:409-15. [DOI: 10.1177/1076029611427900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
80 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
81 Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013;7:369-376. [PMID: 26201771 DOI: 10.1007/s12072-013-9427-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
82 Eshraghian A, Nikeghbalian S, Kazemi K, Mansoorian M, Shamsaeefar A, Eghlimi H, Gholami S, Salahi H, Malek‐hosseini SA. Portal vein thrombosis in patients with liver cirrhosis and its impact on early and long‐term outcomes after liver transplantation. Int J Clin Pract 2018;73:e13309. [DOI: 10.1111/ijcp.13309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
83 Handa P, Crowther M, Douketis JD. Portal vein thrombosis: a clinician-oriented and practical review. Clin Appl Thromb Hemost. 2014;20:498-506. [PMID: 23364162 DOI: 10.1177/1076029612473515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
84 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 56] [Article Influence: 39.5] [Reference Citation Analysis]
85 Yu JI, Park JW, Park HC, Yoon SM, Lim DH, Lee JH, Lee HC, Kim SW, Kim JH. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study. Radiother Oncol. 2016;118:408-415. [PMID: 26830695 DOI: 10.1016/j.radonc.2015.11.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
86 Valeriani E, Riva N, Di Nisio M, Ageno W. Splanchnic Vein Thrombosis: Current Perspectives. Vasc Health Risk Manag 2019;15:449-61. [PMID: 31695400 DOI: 10.2147/VHRM.S197732] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
87 Yu JI, Park HC, Oh D, Noh JM, Jung SH, Kim HY, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial.Int J Hyperthermia. 2016;32:331-338. [PMID: 26915594 DOI: 10.3109/02656736.2016.1144895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
88 Rajani R, Björnsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O, Melin T, Sangfelt P, Wallerstedt S, Almer S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010;32:1154-1162. [PMID: 21039677 DOI: 10.1111/j.1365-2036.2010.04454.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 64] [Article Influence: 8.5] [Reference Citation Analysis]
89 Ahn JH, Yu JS, Cho ES, Chung JJ, Kim JH, Kim KW. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol 2016;17:533-40. [PMID: 27390544 DOI: 10.3348/kjr.2016.17.4.533] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
90 Waits SA, Wojcik BM, Cai S, Mathur AK, Englesbe MJ. Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States. Liver Transpl 2011;17:1066-72. [PMID: 21744467 DOI: 10.1002/lt.22371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
91 Wosiewicz P, Żorniak M, Hartleb M, Barański K, Hartleb M, Onyszczuk M, Pilch-Kowalczyk J, Kyrcz-Krzemień S. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clin Res Hepatol Gastroenterol 2016;40:722-9. [PMID: 27160816 DOI: 10.1016/j.clinre.2016.03.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
92 Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881-894. [PMID: 19678814 DOI: 10.1111/j.1365-2036.2009.04116.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
93 Malaguarnera M, Latteri S, Bertino G, Madeddu R, Catania VE, Currò G, Borzì AM, Drago F, Malaguarnera G. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. Clin Exp Gastroenterol 2018;11:373-80. [PMID: 30323642 DOI: 10.2147/CEG.S172663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
94 Alhaddad O, Elsabaawy M, Elshaaraawy O, Elhalawany M, Houseni MM, Abdelsameea E. Portal vein thrombosis in hepatitis C virus-related cirrhotic patients: Prevalence and clinical characteristics in an Egyptian cohort. Trop Doct 2021;51:314-8. [PMID: 33663297 DOI: 10.1177/0049475521998509] [Reference Citation Analysis]
95 Quarrie R, Stawicki SP. Portal vein thrombosis: What surgeons need to know. Int J Crit Illn Inj Sci. 2018;8:73-77. [PMID: 29963409 DOI: 10.4103/ijciis.ijciis_71_17] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
96 Teng F, Sun KY, Fu ZR. Tailored classification of portal vein thrombosis for liver transplantation: Focus on strategies for portal vein inflow reconstruction. World J Gastroenterol 2020;26:2691-701. [PMID: 32550747 DOI: 10.3748/wjg.v26.i21.2691] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
98 Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Aguilar-Olivos NE, Alva-López LF, Fajardo-Ordoñez E, Ponciano-Rodríguez G, Northup PG, Intagliata N, Caldwell SH, Qi X, Méndez-Sánchez N. Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients. Ann Hepatol 2018;17:476-81. [PMID: 29735798 DOI: 10.5604/01.3001.0011.7392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
99 Cowell GW, Thomson LK, Digby M, Poon FW. Acute portal vein thrombosis: an important mimic of malignancy on FDG PET/CT. BMJ Case Rep 2011;2011:bcr0720114482. [PMID: 22679156 DOI: 10.1136/bcr.07.2011.4482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
100 Deng MH, Liu B, Fang HP, Pan WD, Tang ZF, Deng P, Zhong YS, Xu RY. Predictive value of D-dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis. World J Gastroenterol 2007;13:6588-92. [PMID: 18161932 DOI: 10.3748/wjg.v13.i48.6588] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
101 Tan SBM, Greenslade J, Martin D, Talbot M, Loi K, Hopkins G. Portomesenteric vein thrombosis in sleeve gastrectomy: a 10-year review. Surgery for Obesity and Related Diseases 2018;14:271-5. [DOI: 10.1016/j.soard.2017.12.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
102 Bertoletti L, Benhamou Y, Béjot Y, Marechaux S, Cheggour S, Aleil B, Lellouche N, Dillinger J, Delluc A. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Reviews 2018;32:272-9. [DOI: 10.1016/j.blre.2018.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
103 Luo J, Yan Z, Wang J, Liu Q, Qu X. Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach. J Vasc Interv Radiol. 2011;22:61-69. [PMID: 21106386 DOI: 10.1016/j.jvir.2010.07.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
104 Herber SC, Otto G, Schneider J, Schuchmann M, Düber C, Pitton MB, Kummer I, Manzl N. Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results. AJR Am J Roentgenol. 2008;190:1035-1042. [PMID: 18356452 DOI: 10.2214/ajr.07.2755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
105 Villagrán R, Smith G, Rodriguez W, Flores C, Cariaga M, Araya S, Yañez M, Fuentes P, Linares J, Zapata A. Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: Incidence, Analysis and Follow-Up in 1236 Consecutive Cases. Obes Surg 2016;26:2555-61. [PMID: 27079191 DOI: 10.1007/s11695-016-2183-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
106 Scheiner B, Stammet PR, Pokorny S, Bucsics T, Schwabl P, Brichta A, Thaler J, Lampichler K, Ba-Ssalamah A, Ay C. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function. Wien Klin Wochenschr. 2018;. [PMID: 29916054 DOI: 10.1007/s00508-018-1351-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
107 Gabr MA, Bessa SS, El-Zamarani EA. Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation. Hepatol Res. 2010;40:486-493. [PMID: 20374299 DOI: 10.1111/j.1872-034x.2010.00628.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
108 Pregler B, Beyer LP, Wiesinger I, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P. Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation. Clin Hemorheol Microcirc 2017;67:383-8. [PMID: 28885205 DOI: 10.3233/CH-179218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
109 Diamond JR, Finlayson CA, Borges VF. Hepatic complications of breast cancer. The Lancet Oncology 2009;10:615-21. [DOI: 10.1016/s1470-2045(09)70029-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
110 Ponziani FR, Zocco MA, Garcovich M, D'Aversa F, Roccarina D, Gasbarrini A. What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective. World J Gastroenterol. 2012;18:5014-5020. [PMID: 23049208 DOI: 10.3748/wjg.v18.i36.5014] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
111 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010;31:366-374. [PMID: 19863496 DOI: 10.1111/j.1365-2036.2009.04182.x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 14.5] [Reference Citation Analysis]
113 Di Nisio M, Valeriani E, Riva N, Schulman S, Beyer-Westendorf J, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost 2020;18:1562-8. [PMID: 32619346 DOI: 10.1111/jth.14836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
114 Koc Z, Oguzkurt L, Ulusan S. Portal venous system aneurysms: imaging, clinical findings, and a possible new etiologic factor. AJR Am J Roentgenol. 2007;189:1023-1030. [PMID: 17954635 DOI: 10.2214/ajr.07.2121] [Cited by in Crossref: 65] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
115 Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
116 Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. [PMID: 17697371 DOI: 10.1186/1471-230x-7-34] [Cited by in Crossref: 108] [Cited by in F6Publishing: 32] [Article Influence: 7.7] [Reference Citation Analysis]
117 Robinson KA, O'Donnell ME, Pearson D, Kriegshauser JS, Odeleye M, Kalkbrenner K, Bodnar Z, Young-Fadok TM. Portomesenteric venous thrombosis following major colon and rectal surgery: incidence and risk factors. Surg Endosc 2015;29:1071-9. [PMID: 25159636 DOI: 10.1007/s00464-014-3788-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
118 Tsai HM, Han MZ, Lin YJ, Chang TT, Chen CY, Cheng PN, Chuang CH, Wu IC, Chen PJ, Kang JW, Chiu YC, Chiu HC, Chien SC, Kuo HY. Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis. Cancer Immunol Immunother 2021;70:1929-37. [PMID: 33409737 DOI: 10.1007/s00262-020-02845-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
119 Arai M, Kim S, Ishii H, Hagiwara J, Takiguchi T, Ishiki Y, Yokota H. Delayed development of portal vein thrombosis in a patient initially detected with portal venous gas and pneumatosis intestinalis: a case report. Acute Med Surg 2019;6:419-22. [PMID: 31592325 DOI: 10.1002/ams2.448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
120 Farmer AD, Saadeddin A, Bruckner Holt CE, Bateman JM, Ahmed M, Syn WK. Portal vein thrombosis in the district general hospital: management and clinical outcomes: . European Journal of Gastroenterology & Hepatology 2009;21:517-21. [DOI: 10.1097/meg.0b013e328318ed6b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
121 Sofia C, Cattafi A, Silipigni S, Pitrone P, Carerj ML, Marino MA, Pitrone A, Ascenti G. Portal vein thrombosis in patients with chronic liver diseases: From conventional to quantitative imaging. Eur J Radiol 2021;142:109859. [PMID: 34284232 DOI: 10.1016/j.ejrad.2021.109859] [Reference Citation Analysis]
122 Shoar S, Saber AA, Rubenstein R, Safari S, Brethauer SA, Al-thani H, Asarian AP, Aminian A. Portomesentric and splenic vein thrombosis (PMSVT) after bariatric surgery: a systematic review of 110 patients. Surgery for Obesity and Related Diseases 2018;14:47-59. [DOI: 10.1016/j.soard.2017.09.512] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 8.7] [Reference Citation Analysis]
123 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16:143-155. [PMID: 20066733 DOI: 10.3748/wjg.v16.i2.143] [Cited by in CrossRef: 143] [Cited by in F6Publishing: 101] [Article Influence: 13.0] [Reference Citation Analysis]
124 Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg 2011;21:1657-63. [PMID: 21898042 DOI: 10.1007/s11695-011-0499-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
125 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
126 Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384-93. [DOI: 10.1002/hep.22192] [Cited by in Crossref: 77] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
127 Cool J, Rosenblatt R, Kumar S, Lucero C, Fortune B, Crawford C, Jesudian A. Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort. Journal of Gastroenterology and Hepatology 2018;34:1088-92. [DOI: 10.1111/jgh.14501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
128 Northup P, Reutemann B. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates. Liver Transpl 2018;24:1119-32. [DOI: 10.1002/lt.25198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
129 Knight GM, Clark J, Boike JR, Maddur H, Ganger DR, Talwar A, Riaz A, Desai K, Mouli S, Hohlastos E, Garcia Pagan JC, Gabr A, Stein B, Lewandowski R, Thornburg B, Salem R. TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care Therapy. Hepatology 2021. [PMID: 34021505 DOI: 10.1002/hep.31915] [Reference Citation Analysis]
130 Mamad H, Benkirane S, El Aissaoui Y, Berchane Z, Nahm-Tchougli Christiana PL, Masrar A. Prothrombotic disorders in non-cirrhotic, non-tumoral portal vein thrombosis. Thromb Res 2021;203:152-4. [PMID: 34022674 DOI: 10.1016/j.thromres.2021.04.025] [Reference Citation Analysis]
131 Björck M, Koelemay M, Acosta S, Bastos Goncalves F, Kölbel T, Kolkman JJ, Lees T, Lefevre JH, Menyhei G, Oderich G, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Sanddal Lindholt J, Vega de Ceniga M, Vermassen F, Verzini F, Document Reviewers, Geelkerken B, Gloviczki P, Huber T, Naylor R. Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53:460-510. [PMID: 28359440 DOI: 10.1016/j.ejvs.2017.01.010] [Cited by in Crossref: 190] [Cited by in F6Publishing: 131] [Article Influence: 63.3] [Reference Citation Analysis]
132 Trebicka J, Strassburg CP. Etiology and Complications of Portal Vein Thrombosis. Viszeralmedizin. 2014;30:375-380. [PMID: 26288604 DOI: 10.1159/000369987] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
133 El-Karaksy HM, El-Koofy N, Mohsen N, Helmy H, Nabil N, El-Shabrawi M. Extrahepatic portal vein obstruction in Egyptian children. J Pediatr Gastroenterol Nutr 2015;60:105-9. [PMID: 25546337 DOI: 10.1097/MPG.0000000000000548] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
134 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]
135 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 291] [Cited by in F6Publishing: 182] [Article Influence: 48.5] [Reference Citation Analysis]
136 Gisbert JP. [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer]. Gastroenterol Hepatol. 2008;31 Suppl 4:18-28. [PMID: 19434862 DOI: 10.1157/13114566] [Reference Citation Analysis]
137 Klute K, DeFilippis EM, Shillingford K, Chapin J, DeSancho MT. Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience. J Thromb Thrombolysis. 2016; Feb 1. [Epub ahead of print]. [PMID: 26831481 DOI: 10.1007/s11239-016-1337-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421-441. [PMID: 23978714 DOI: 10.1016/j.jhep.2013.08.013] [Cited by in Crossref: 170] [Cited by in F6Publishing: 113] [Article Influence: 21.3] [Reference Citation Analysis]
139 Quencer KB, Friedman T, Sheth R, Oklu R. Tumor thrombus: incidence, imaging, prognosis and treatment. Cardiovasc Diagn Ther 2017;7:S165-77. [PMID: 29399520 DOI: 10.21037/cdt.2017.09.16] [Cited by in Crossref: 50] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
140 Li C, Hu J, Zhou D, Zhao J, Ma K, Yin X, Wang J. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer. 2014;14:590. [PMID: 25123782 DOI: 10.1186/1471-2407-14-590] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
141 Kirschner M, do Ó Hartmann N, Parmentier S, Hart C, Henze L, Bisping G, Griesshammer M, Langer F, Pabinger-Fasching I, Matzdorff A, Riess H, Koschmieder S. Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO). Cancers (Basel) 2021;13:2905. [PMID: 34200741 DOI: 10.3390/cancers13122905] [Reference Citation Analysis]
142 Salinas J, Barros D, Salgado N, Viscido G, Funke R, Pérez G, Pimentel F, Boza C. Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy. Surg Endosc 2014;28:1083-9. [DOI: 10.1007/s00464-013-3055-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
143 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 28.0] [Reference Citation Analysis]
144 Jian J, Yang H, Zhao X, Xuan R, Zhang Y, Li D, Hu C. Visualization of microvasculature and thrombi by X-ray phase-contrast computed tomography in hepatocellular carcinoma. J Synchrotron Radiat 2016;23:600-5. [PMID: 26917149 DOI: 10.1107/S1600577516001016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
145 Girleanu I, Stanciu C, Cojocariu C, Boiculese L, Singeap AM, Trifan A. Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol. 2014;20:288-292. [PMID: 25253363 DOI: 10.4103/1319-3767.141687] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
146 Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol. 2015;7:2774-2780. [PMID: 26644821 DOI: 10.4254/wjh.v7.i27.2774] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
147 Lertpipopmetha K, Auewarakul CU. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol. 2011;11:66. [PMID: 21658275 DOI: 10.1186/1471-230x-11-66] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
148 Dumic I, Tankosic N, Stojkovic Lalosevic M, Alempijevic T. Sport-Related Portal Vein Thrombosis: An Unusual Complication. Case Reports Hepatol 2017;2017:9324246. [PMID: 29259831 DOI: 10.1155/2017/9324246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
149 Ferro D, Angelico F, Caldwell SH, Violi F. Bleeding and thrombosis in cirrhotic patients: what really matters? Dig Liver Dis. 2012;44:275-279. [PMID: 22119620 DOI: 10.1016/j.dld.2011.10.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
150 Gonzales Aguilar JD, Ramia Angel JM, de la Plaza Llamas R, Kuhnhardt Barrantes AW, Ramiro Perez C, Valenzuela Torres JDC, Garcia-amador C, Lopez-marcano AJ. Trombosis portal y necrosis hepática: complicación excepcional de la pancreatitis aguda. Gastroenterología y Hepatología 2017;40:88-90. [DOI: 10.1016/j.gastrohep.2016.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern. Emerg Med. 2010;5:487-494. [PMID: 20532730 DOI: 10.1007/s11739-010-0413-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
152 Ferri PM, Ferreira AR, Fagundes ED, Liu SM, Roquete ML, Penna FJ. Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center. Arq Gastroenterol 2012;49:69-76. [PMID: 22481689 DOI: 10.1590/s0004-28032012000100012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
153 Tremblay D, Naymagon L, Troy K, Cromwell C, Edwards C, Schiano T, Kremyanskaya M, Mascarenhas J. The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis. Blood Coagul Fibrinolysis 2020;31:213-8. [PMID: 32101880 DOI: 10.1097/MBC.0000000000000901] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
154 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Clinics in Liver Disease 2009;13:127-44. [DOI: 10.1016/j.cld.2008.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
155 Swallow G, Pavord S. Portal vein thrombosis - experience in a single centre. Br J Haematol 2012;159:482-4. [DOI: 10.1111/bjh.12037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
156 Aumann EK, Server S, Koyuncu Sokmen B, Oz A, Namal E, Gurcan NI, Balci NC, Tokat Y. Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus. Abdom Radiol (NY) 2018;43:2270-6. [PMID: 29411058 DOI: 10.1007/s00261-018-1467-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis. 2009;1:e2009014. [PMID: 21415954 DOI: 10.4084/mjhid.2009.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
158 Takahashi S, Kimura T, Kenjo M, Nishibuchi I, Takahashi I, Takeuchi Y, Doi Y, Kaneyasu Y, Murakami Y, Honda Y, Aikata H, Chayama K, Nagata Y. Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma: Portal vein/bile duct toxicity after SBRT. Hepatol Res 2014;44:E273-8. [DOI: 10.1111/hepr.12241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
159 Rodriguez-castro KI, Simioni P, Burra P, Senzolo M. Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int 2012;32:1465-76. [DOI: 10.1111/j.1478-3231.2012.02839.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
160 Lee WK, Chang SD, Duddalwar VA, Comin JM, Perera W, Lau WF, Bekhit EK, Hennessy OF. Imaging assessment of congenital and acquired abnormalities of the portal venous system. Radiographics 2011;31:905-26. [PMID: 21768231 DOI: 10.1148/rg.314105104] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
161 Regnault H, Emambux S, Lecomte T, Doat S, Dhooge M, Besson M, Dubreuil O, Moryoussef F, Silvain C, Bachet JB, Tougeron D. Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study. Dig Liver Dis 2018;50:285-90. [PMID: 29183764 DOI: 10.1016/j.dld.2017.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
162 Hoekstra J, Bresser EL, Smalberg JH, Spaander MCW, Leebeek FWG, Janssen HLA. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms: Portal vein thrombosis and myeloproliferative neoplasms. Journal of Thrombosis and Haemostasis 2011;9:2208-14. [DOI: 10.1111/j.1538-7836.2011.04484.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
163 Abdel-Razik A, Mousa N, Elhelaly R, Tawfik A. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system. Eur J Gastroenterol Hepatol 2015;27:585-92. [PMID: 25769098 DOI: 10.1097/MEG.0000000000000325] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
164 Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16:999-1005. [PMID: 20677291 DOI: 10.1002/lt.22105] [Cited by in Crossref: 147] [Cited by in F6Publishing: 112] [Article Influence: 13.4] [Reference Citation Analysis]
165 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
166 Cai XY, Zhou W, Hong DF, Cai XJ. A latent form of essential thrombocythemia presenting as portal cavernoma. World J Gastroenterol 2009;15:5368-70. [PMID: 19908349 DOI: 10.3748/wjg.15.5368] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Lee AYY, Peterson EA. Treatment of cancer-associated thrombosis. Blood 2013;122:2310-7. [DOI: 10.1182/blood-2013-04-460162] [Cited by in Crossref: 95] [Cited by in F6Publishing: 72] [Article Influence: 11.9] [Reference Citation Analysis]
168 Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP. Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis: Similarities and Differences. Arterioscler Thromb Vasc Biol 2011;31:485-93. [DOI: 10.1161/atvbaha.110.213371] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
169 Søgaard KK, Darvalics B, Horváth–puhó E, Sørensen HT. Survival after splanchnic vein thrombosis: A 20-year nationwide cohort study. Thrombosis Research 2016;141:1-7. [DOI: 10.1016/j.thromres.2016.02.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
170 Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200-219. [PMID: 23579878 DOI: 10.1007/s00508-013-0337-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
171 Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921-4928. [PMID: 23043069 DOI: 10.1182/blood-2011-09-376517] [Cited by in Crossref: 194] [Cited by in F6Publishing: 135] [Article Influence: 21.6] [Reference Citation Analysis]
172 Kim JH, Lee JM, Yoon JH, Lee DH, Lee KB, Han JK, Choi BI. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging. Radiology. 2016;279:773-783. [PMID: 26780538 DOI: 10.1148/radiol.2015150124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
173 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
174 Bartolotta TV, Terranova MC, Gagliardo C, Taibbi A. CEUS LI-RADS: a pictorial review. Insights Imaging. 2020;11:9. [PMID: 32020352 DOI: 10.1186/s13244-019-0819-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
175 Galante A, De Gottardi A. Portal vein thrombosis: an overview of current treatment options. Acta Gastroenterol Belg 2021;84:327-32. [PMID: 34217184 DOI: 10.51821/84.2.327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Deng MH, Liu B, Fang HP, Pan WD, Tang ZF, Deng P, Zhong YS, Xu RY. Predictive value of D-dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis. World J Gastroenterol. 2007;13:6588-6592. [PMID: 18161932 DOI: 10.3748/wjg.13.6588] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
177 Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Méndez-Sánchez N. Effects of Portal Vein Thrombosis on the Outcomes of Liver Cirrhosis: A Mexican Perspective. J Transl Int Med 2017;5:189-91. [PMID: 29340273 DOI: 10.1515/jtim-2017-0031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
178 Rodrigues SG, Maurer MH, Baumgartner I, De Gottardi A, Berzigotti A. Imaging and minimally invasive endovascular therapy in the management of portal vein thrombosis. Abdom Radiol (NY). 2018;43:1931-1946. [PMID: 28983654 DOI: 10.1007/s00261-017-1335-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
179 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
180 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
181 Elsayes KM, Shaaban AM, Rothan SM, Javadi S, Madrazo BL, Castillo RP, Casillas VJ, Menias CO. A Comprehensive Approach to Hepatic Vascular Disease. RadioGraphics 2017;37:813-36. [DOI: 10.1148/rg.2017160161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
182 Gorgun E, Sapci I, Onder A, Ozuner G, Liska D, Stocchi L, Delaney CP. Factors associated with portomesenteric venous thrombosis after total colectomy with ileorectal anastomosis or end ileostomy. The American Journal of Surgery 2018;215:62-5. [DOI: 10.1016/j.amjsurg.2017.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
183 Sekhar M, McVinnie K, Burroughs AK. Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 2013;162:730-47. [PMID: 23855810 DOI: 10.1111/bjh.12461] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
184 Ogren M, Bergqvist D, Björck M, Acosta S, Sternby NH. High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsies. J Thromb Haemost 2007;5:198-200. [PMID: 17059416 DOI: 10.1111/j.1538-7836.2006.02264.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
185 Parikh NS, Navi BB, Kumar S, Kamel H. Association between Liver Disease and Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2016;25:543-548. [PMID: 26679070 DOI: 10.1016/j.jstrokecerebrovasdis.2015.11.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
186 Hunninghake J, Murray BP, Ferraro D, Gancayco J. Acute intestinal ischaemia from a portal vein thrombosis in a young female smoker on an oral contraceptive. BMJ Case Rep 2018;2018:bcr-2018-225135. [PMID: 30077981 DOI: 10.1136/bcr-2018-225135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
187 Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?: TRANSFUSION IN CIRRHOSIS. Transfusion 2016;56:791-8. [DOI: 10.1111/trf.13495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
188 Ascenti G, Sofia C, Mazziotti S, Silipigni S, D'angelo T, Pergolizzi S, Scribano E. Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma. Clinical Radiology 2016;71:938.e1-9. [DOI: 10.1016/j.crad.2016.05.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
189 Galloula A, Rossi A, Gautier V, Minozzi C, Messas E, Mirault T. Thrombose portale associée à une infection aiguë à cytomégalovirus. Journal des Maladies Vasculaires 2014;39:224-30. [DOI: 10.1016/j.jmv.2014.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
190 Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. [PMID: 17697371 DOI: 10.1186/1471-230x-7-34/] [Reference Citation Analysis]
191 Takamatsu M, Furutake M, Hisa T, Ueda M. Obstructive jaundice caused by a portal cavernoma. Jpn J Radiol. 2010;28:754-758. [PMID: 21191741 DOI: 10.1007/s11604-010-0480-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
192 Sacerdoti D, Serianni G, Gaiani S, Bolognesi M, Bombonato G, Gatta A. Thrombosis of the portal venous system. J Ultrasound 2007;10:12-21. [PMID: 23396402 DOI: 10.1016/j.jus.2007.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
193 Riva N, Dentali F, Donadini MP, Squizzato A, Ageno W. Risk of recurrence of unusual site venous thromboembolism. Hamostaseologie 2017;33:225-31. [DOI: 10.5482/hamo-13-03-0006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
194 Lee H, Park SJ, Yi B, Yeon E, Kim JH, Hong H. Portal vein thrombosis: CT features. Abdom Imaging 2008;33:72-9. [DOI: 10.1007/s00261-007-9200-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]